MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-19-2024
Renalytix AI plc ROE Ratio 2011-2026 | RNLX
Annual ROE Ratio Renalytix AI plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 425.97 | -654.61 | -147.93 | -49.45 | -61.87 | -494.69 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 425.97 | -654.61 | -163.76 |
Quarterly ROE Ratio Renalytix AI plc
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 287.79 | 857.36 | 790.46 | 653.88 | 429.68 | -247.88 | -297.83 | -280.9 | -196.8 | -100.26 | -111.23 | -72.24 | -49.29 | -30.21 | -30.21 | -19.24 | -8.74 | - | - | - | - | 113.94 | 227.89 | 227.89 | 113.94 | 113.94 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 857.36 | -297.83 | 107.82 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
-5.13 | $ 20.41 | 1.9 % | $ 592 M |  USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 17.34 | 5.67 % | $ 524 M | USA |
 |
Guardant Health
GH
|
419.21 | $ 118.55 | 3.11 % | $ 14.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 115.14 | 0.04 % | $ 9.5 B |  Irlanda |
 |
Illumina
ILMN
|
-51.54 | $ 144.35 | 1.71 % | $ 23 B | USA |
 |
Agilent Technologies
A
|
22.45 | $ 113.97 | 0.21 % | $ 34.6 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 141.62 | 0.91 % | $ 6.62 B | USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 3.88 | 62.44 % | $ 5.16 M | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 21.66 | 2.39 % | $ 1.15 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 94.6 | -1.56 % | $ 6.38 B | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.8 | - | $ 7.96 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 424.51 | 0.63 % | $ 12.2 B | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 086.52 | 0.31 % | $ 22.4 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Natera
NTRA
|
-77.62 | $ 204.45 | -0.23 % | $ 20.1 B | USA |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Personalis
PSNL
|
-31.12 | $ 8.3 | 4.4 % | $ 741 M | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 159.56 | 2.22 % | $ 7.91 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.96 | 0.67 % | $ 1.15 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 19.06 | -1.04 % | $ 427 M | USA |
 |
Myriad Genetics
MYGN
|
-99.46 | $ 3.81 | -0.13 % | $ 353 M | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 448.97 | -0.59 % | $ 169 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 27.16 | 1.61 % | $ 25.8 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 55.04 | 2.57 % | $ 3.29 B | USA |
 |
Senseonics Holdings
SENS
|
-113.19 | $ 5.96 | 4.38 % | $ 249 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.41 | 2.55 % | $ 5.54 M | USA |
 |
Waters Corporation
WAT
|
25.09 | $ 339.58 | -0.48 % | $ 20.2 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 254.26 | -1.19 % | $ 21.2 B | USA |
 |
Trinity Biotech plc
TRIB
|
88.73 | $ 0.62 | 2.96 % | $ 223 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Exagen
XGN
|
-114.34 | $ 4.06 | 6.01 % | $ 87.5 M | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 8.77 | -0.68 % | $ 1.9 B | USA |